High-dose erlotinib for refractory leptomeningeal metastases after failure of standard-dose EGFR-TKIs
Crossref DOI link: https://doi.org/10.1007/s00280-015-2759-y
Published Online: 2015-04-29
Published Print: 2015-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kawamura, Takahisa
Hata, Akito
Takeshita, Jumpei
Fujita, Shiro
Hayashi, Michio
Tomii, Keisuke
Katakami, Nobuyuki
Text and Data Mining valid from 2015-04-29